Furthermore, our findings suggest that although TP53 mutations are often considered a negative prognostic factor in EGFR-mutant NSCLC, their impact may be context-dependent and influenced by additional comutations, such as CTNNB1. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.